{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:08:15Z","timestamp":1761311295168},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.braindev.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T15:15:54Z","timestamp":1506352554000},"page":"100-106","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Correlations between UGT2B7\u22172 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients"],"prefix":"10.1016","volume":"40","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuechun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2017.09.004_b0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3349\/ymj.2014.55.1.232","article-title":"Comprehensive variant screening of the UGT gene family","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.braindev.2017.09.004_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(02)01522-8","article-title":"Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7","volume":"65","author":"Mackenzie","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.braindev.2017.09.004_b0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinbiochem.2006.01.002","article-title":"Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects","volume":"39","author":"Saito","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.braindev.2017.09.004_b0020","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-03-3219","article-title":"Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes","volume":"64","author":"Wiener","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.braindev.2017.09.004_b0025","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/QAD.0b013e3283319908","article-title":"CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-doseconcentration in HIV-infected patients","volume":"23","author":"Kwara","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.braindev.2017.09.004_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0009-9236(03)00053-5","article-title":"A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine","volume":"73","author":"Sawyer","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.braindev.2017.09.004_b0035","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr2894","article-title":"Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer","volume":"13","author":"Parmar","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.braindev.2017.09.004_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eplepsyres.2015.04.015","article-title":"The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"114","author":"Sun","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2017.09.004_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.dmpk.2014.12.007","article-title":"Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy","volume":"30","author":"Wang","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.braindev.2017.09.004_b0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","article-title":"Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"68","author":"Chu","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2017.09.004_b0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":"Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.braindev.2017.09.004_b0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2217\/pgs-2016-0014","article-title":"UGT1A6- and UGT2B7-related valproic acid pharmacogenomics according to age groups and total drug concentration levels","volume":"17","author":"Chatzistefanidis","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.braindev.2017.09.004_b0065","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/jpet.104.073114","article-title":"N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7","volume":"311","author":"Staines","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.braindev.2017.09.004_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2217\/pgs.11.141","article-title":"Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization","volume":"13","author":"Hung","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.braindev.2017.09.004_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/pgs.12.180","article-title":"Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy","volume":"14","author":"Puranik","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.braindev.2017.09.004_b0080","first-page":"766","article-title":"Effect of UGT2B7 genetic variants on serum valproic acid concentration","volume":"38","author":"Ma","year":"2013","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.braindev.2017.09.004_b0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clineuro.2010.01.002","article-title":"The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients","volume":"112","author":"Tan","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2017.09.004_b0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/FTD.0000000000000012","article-title":"Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients","volume":"36","author":"Inoue","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2017.09.004_b0095","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.104.001313","article-title":"Evidence of significant contribution from CYP3A5 to hepatic drug metabolism","volume":"32","author":"Huang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.braindev.2017.09.004_b0100","first-page":"7","article-title":"Study of population pharmacokinetics of carbamazepine and on genetic polymorphism of metabolic enzyme CYP3A4","volume":"5","author":"Song","year":"2010","journal-title":"Shanxi Medical University"},{"key":"10.1016\/j.braindev.2017.09.004_b0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/dmd.31.5.677","article-title":"Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy","volume":"31","author":"Hirota","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.braindev.2017.09.004_b0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00008571-200011000-00002","article-title":"Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance","volume":"10","author":"Bhasker","year":"2000","journal-title":"Pharmacogenetics"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760417302413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760417302413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T08:33:34Z","timestamp":1535358814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760417302413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0387760417302413"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2017.09.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations between UGT2B7\u22172 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}